Covered recipient · General Payments record
RALPH R GARRAMONE
Allopathic & Osteopathic Physicians Plastic Surgery
General Payments · PY2018–2024
$41,565.29
- Reported across 193 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,245.73 | 32 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $843.97 | 21 |
| REVANCE THERAPEUTICS, INC. | $254.45 | 7 |
| Dilon Technologies, Inc. | $105.80 | 2 |
| MOTIVA USA, LLC | $21.55 | 1 |
| Galderma Laboratories, L.P. | $19.96 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.41 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103777931 | CMS |
| ABBVIE INC. | $19.74 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103777933 | CMS |
| ABBVIE INC. | $124.24 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103777935 | CMS |
| ABBVIE INC. | $25.40 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103777937 | CMS |
| ABBVIE INC. | $148.49 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103777939 | CMS |
| ABBVIE INC. | $21.55 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103777941 | CMS |
| ABBVIE INC. | $19.57 | 04/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103777943 | CMS |
| ABBVIE INC. | $17.86 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103777945 | CMS |
| ABBVIE INC. | $40.94 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103777947 | CMS |
| ABBVIE INC. | $29.89 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103777949 | CMS |
| ABBVIE INC. | $31.97 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103777951 | CMS |
| ABBVIE INC. | $24.62 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103777953 | CMS |
| ABBVIE INC. | $116.31 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103777955 | CMS |
| ABBVIE INC. | $5.99 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103777957 | CMS |
| ABBVIE INC. | $9.00 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103777959 | CMS |
| ABBVIE INC. | $18.61 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103777961 | CMS |
| ABBVIE INC. | $3.92 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103777963 | CMS |
| ABBVIE INC. | $1.50 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103777965 | CMS |
| ABBVIE INC. | $12.50 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103777967 | CMS |
| ABBVIE INC. | $144.46 | 12/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103777969 | CMS |
| ABBVIE INC. | $4.00 | 12/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103777971 | CMS |
| Dilon Technologies, Inc. | $13.45 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112838895 | CMS |
| Dilon Technologies, Inc. | $92.35 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112838897 | CMS |
| Galderma Laboratories, L.P. | $19.96 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145298936 | CMS |
| MOTIVA USA, LLC | $21.55 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139154456 | CMS |
| REVANCE THERAPEUTICS, INC. | $25.86 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147918360 | CMS |
| REVANCE THERAPEUTICS, INC. | $46.40 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147918362 | CMS |
| REVANCE THERAPEUTICS, INC. | $30.34 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147918364 | CMS |
| REVANCE THERAPEUTICS, INC. | $29.02 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147918366 | CMS |
| REVANCE THERAPEUTICS, INC. | $30.15 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147918368 | CMS |
| REVANCE THERAPEUTICS, INC. | $71.43 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147918370 | CMS |
| REVANCE THERAPEUTICS, INC. | $21.25 | 12/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147918372 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.